Back to Search
MARK ROTHENBERG, MD
MD
Interventional Cardiology Physician
NPI: 1821024761IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
ME70659(FL)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
ME70659(FL)
CMS Specialties
PrimaryINTERVENTIONAL CARDIOLOGY
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)INTERNAL MEDICINE
Education
MEDICAL COLLEGE OF PENNSYLVANIA
Class of 1989
Research & Publications (20)
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis.
PMID 19528036·Gut·2010
8-other
Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation.
PMID 19201890·J Immunol·2009
7-preclinical
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.
PMID 19194116·Am J Clin Oncol·2009
3-trial
Voice onset time versus articulatory modeling for stop consonants.
PMID 19513923·Logoped Phoniatr Vocol·2009
8-other
Murine model of hypereosinophilic syndromes/chronic eosinophilic leukemia.
PMID 19494514·Int Arch Allergy Immunol·2009
6-review
Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice.
PMID 19486531·BMC Immunol·2009
7-preclinical
Eosinophilic esophagitis: concepts, controversies, and evidence.
PMID 19463222·Curr Gastroenterol Rep·2009
6-review
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression.
PMID 19342679·J Immunol·2009
7-preclinical
Molecular diagnostics and treatment of patients with the hypereosinophilic syndrome.
PMID 19274040·Clin Adv Hematol Oncol·2009
8-other
Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.
PMID 19255847·Dig Dis Sci·2009
5-case
Functional characterization and modulation of the DNA cleavage efficiency of type III restriction endonuclease EcoP15I in its interaction with two sites in the DNA target.
PMID 19250940·J Mol Biol·2009
8-other
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.
PMID 19203899·Clin Colorectal Cancer·2009
3-trial
CCR3 is a target for age-related macular degeneration diagnosis and therapy.
PMID 19525930·Nature·2009
7-preclinical
Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis.
PMID 19179876·J Pediatr Gastroenterol Nutr·2009
8-other
Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.
PMID 19147836·Int Immunol·2009
7-preclinical
Chemotactic factors associated with eosinophilic gastrointestinal diseases.
PMID 19141349·Immunol Allergy Clin North Am·2009
6-review
Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner.
PMID 19641187·Blood·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5503 S CONGRESS AVE, SUITE 206
ATLANTIS, FL 33462 - Phone
- (561) 433-0591
Quick Facts
- NPI
- 1821024761
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile